These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19490544)

  • 1. Outcome of liver transplantation in hereditary hemochromatosis.
    Dar FS; Faraj W; Zaman MB; Bartlett A; Bomford A; O'Sullivan A; O'Grady J; Heneghan M; Rela M; Heaton ND
    Transpl Int; 2009 Jul; 22(7):717-24. PubMed ID: 19490544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis.
    Crawford DH; Fletcher LM; Hubscher SG; Stuart KA; Gane E; Angus PW; Jeffrey GP; McCaughan GW; Kerlin P; Powell LW; Elias EE
    Hepatology; 2004 Jun; 39(6):1655-62. PubMed ID: 15185307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
    von Delius S; Lersch C; Schulte-Frohlinde E; Fend F; Dobritz M; Schmid RM; Eckel F
    Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
    Scatton O; Zalinski S; Terris B; Lefevre JH; Casali A; Massault PP; Conti F; Calmus Y; Soubrane O
    Liver Transpl; 2008 Jun; 14(6):779-88. PubMed ID: 18508370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of immunosuppression withdrawal after liver transplantation.
    Girlanda R; Rela M; Williams R; O'Grady JG; Heaton ND
    Transplant Proc; 2005 May; 37(4):1708-9. PubMed ID: 15919439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.
    Fracanzani AL; Conte D; Fraquelli M; Taioli E; Mattioli M; Losco A; Fargion S
    Hepatology; 2001 Mar; 33(3):647-51. PubMed ID: 11230745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of liver transplantation in patients with advanced hepatocellular carcinoma.
    Li N; Zhou J; Weng D; Zhang C; Li L; Wang B; Song Y; He Q; Lin D; Chen D; Chen G; Gao Q; Wang S; Xu G; Meng L; Lu Y; Ma D
    Clin Cancer Res; 2007 Oct; 13(19):5847-54. PubMed ID: 17908978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
    Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
    Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of liver transplantation in patients with hemochromatosis.
    Farrell FJ; Nguyen M; Woodley S; Imperial JC; Garcia-Kennedy R; Man K; Esquivel CO; Keeffe EB
    Hepatology; 1994 Aug; 20(2):404-10. PubMed ID: 8045502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.
    D'Amico F; Schwartz M; Vitale A; Tabrizian P; Roayaie S; Thung S; Guido M; del Rio Martin J; Schiano T; Cillo U
    Liver Transpl; 2009 Oct; 15(10):1278-87. PubMed ID: 19790142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic liver resection facilitates salvage liver transplantation for hepatocellular carcinoma.
    Laurent A; Tayar C; Andréoletti M; Lauzet JY; Merle JC; Cherqui D
    J Hepatobiliary Pancreat Surg; 2009; 16(3):310-4. PubMed ID: 19280110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for metabolic liver diseases in adults: indications and outcome.
    Weiss KH; Gotthardt D; Schmidt J; Schemmer P; Encke J; Riediger C; Stremmel W; Sauer P; Merle U
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii9-viii12. PubMed ID: 17890269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver retransplantation: a single-centre experience.
    Ma Y; Wang GD; He XS; Li JL
    Chin Med J (Engl); 2008 Oct; 121(20):1987-91. PubMed ID: 19080261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term results of venesection therapy in idiopathic haemochromatosis.
    Bomford A; Williams R
    Q J Med; 1976 Oct; 45(180):611-23. PubMed ID: 188063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients.
    Milman N; Pedersen P; á Steig T; Byg KE; Graudal N; Fenger K
    Ann Hematol; 2001 Dec; 80(12):737-44. PubMed ID: 11797115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent nonhepatic and de novo malignancies after liver transplantation.
    Jain A; Fiaz O; Sheikh B; Sharma R; Safadjou S; Kashyap R; Bryan L; Batzold P; Orloff M
    Transplantation; 2009 Sep; 88(5):706-10. PubMed ID: 19741469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation for liver failure in patients with sickle cell disease: challenging but feasible.
    Hurtova M; Bachir D; Lee K; Calderaro J; Decaens T; Kluger MD; Zafrani ES; Cherqui D; Mallat A; Galactéros F; Duvoux C
    Liver Transpl; 2011 Apr; 17(4):381-92. PubMed ID: 21445921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
    Pelletier SJ; Fu S; Thyagarajan V; Romero-Marrero C; Batheja MJ; Punch JD; Magee JC; Lok AS; Fontana RJ; Marrero JA
    Liver Transpl; 2009 Aug; 15(8):859-68. PubMed ID: 19642139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.